microbiome

News

MHRA clarifies UK position on microbiome-based medicines

The MHRA has published its position paper clarifying how microbiome-based medicines can be made available for patients in the UK.

Oncology

ASCO 2026: Powerful evidence for the microbiome in oncology,...

Can the state of someone’s gut microbiome – the balance of good and bad bacteria in their digestive tract – affect their response to cancer immunother

R&D

The long-delayed promise of the microbiome, with Sam Possemi...

Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.

News

Vedanta's microbiome therapy for IBD disappoints

Vedanta's microbiome therapy for ulcerative colitis has failed a phase 2 trial and will be shelved, prompting a 20% cut in workforce.

News

EnteroBiotix cues up larger trial of microbiome IBS therapy

EnteroBiotix has reported phase 2a proof-of-concept data for its therapy for irritable bowel syndrome (IBS) based on gut microbiome species.

News

Nestle bids to take control of Seres’ C diff drug Vowst

Swiss food giant Nestlé has said it wants to take full ownership of Seres Therapeutics’ Vowst microbiome therapy for Clostridiodes difficile infections (CDI), upg

MHRA clarifies UK position on microbiome-based medicines

ASCO 2026: Powerful evidence for the microbiome in oncology,...

The long-delayed promise of the microbiome, with Sam Possemi...

Vedanta's microbiome therapy for IBD disappoints

EnteroBiotix cues up larger trial of microbiome IBS therapy

Nestle bids to take control of Seres’ C diff drug Vowst

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

microbiome

Editor's Picks